Maxis AI launches MaxisAI Holarchy, the first Verticalized Context Layer for life sciences.Learn More →

    White Papers Gated White Paper

    White Paper

    AI and Human Oversight: A Risk-Based Framework for Alignment

    A practical risk-based framework for preserving human judgment, ethics, accountability, patient safety, and regulatory confidence as AI transforms clinical research and life sciences.

    White PaperNovember 15, 2025White Paper
    AI and Human Oversight: A Risk-Based Framework for Alignment whitepaper cover and author Laxmiraju Kandikatla

    About this white paper

    What's inside

    As AI transforms clinical development, data management, and decision-making, preserving human judgment, ethics, and accountability is essential. This whitepaper presents a structured, scalable framework that links AI model risk with the right level of human oversight. Drawing on examples from clinical operations, pharmacovigilance, and patient data management, it explains how Human-in-Command, Human-in-the-Loop, and Human-on-the-Loop models can balance automation with patient safety, data integrity, compliance, and regulatory confidence.

    Key takeaways

    What you'll learn

    • How to identify where human involvement matters most, from AI-enabled patient recruitment to risk-based monitoring and adverse event reporting.
    • How structured oversight preserves investigator judgment, patient safety, human agency, and transparent clinical decisions.
    • How to apply ISO 31000 and EU AI Act principles to align model risk with oversight intensity in GxP-regulated environments.
    • How Human-in-Command, Human-in-the-Loop, and Human-on-the-Loop models can support accountable clinical operations.
    • How risk-based human oversight strengthens trust, auditability, and regulatory confidence without slowing responsible innovation.
    Laxmiraju Kandikatla

    About the author

    Laxmiraju Kandikatla

    CSV Lead, Maxis AI

    Laxmiraju Kandikatla brings 13+ years of experience across life sciences, pharmaceutical, and clinical research sectors. As CSV Lead at Maxis AI, he leads validation and compliance frameworks for clinical research systems, with hands-on experience across GAMP 5 Categories 3, 4, and 5. He holds an M.Pharm from NIPER and is an ASQ-Certified Quality Auditor, with expertise in GxP, 21 CFR Part 11, EU Annex 11, and FDA guidance.